$Nukkleus (NUKK.US)$ buy now or regret later

$BioAtla (BCAB.US)$
BioAtla Presented Data Characterizing Mutated KRAS Genotype and Clinical Outcomes in Patients with Advanced NSCLC Treated with Mecbotamab Vedotin (Mec-V), a CAB-AXL-ADC, at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting
Monday, 16th December at 8:00 am
Improved median overall survival (OS) for Mec-V treated patients with treatment-refractory non-small cell lung cancer (NSCLC) expressing mutated KRAS (mKRAS) as compared to Mec-V treated patient with treat...

$Protara Therapeutics (TARA.US)$ 10?

$Senti Biosciences (SNTI.US)$
Risk Level: 8/10 (High Risk)
The stock presents a high-risk opportunity, given its dependency on successful resolution of clinical trials and the volatile nature of biotechnology investments. Senti Biosciences faces substantial financial hurdles, as reflected in its low profitability score and significant net losses. While recent news surrounding positive trial results has temporarily buoyed the stock, the broader financial health of the company is precarious. The ma...

$Safe Pro Group (SPAI.US)$ this is one of those stocks which you should avoid trading, someone's playground

$CERo Therapeutics (CERO.US)$  whats going on ?

$FOXO Technologies (FOXO.US)$ time to load more!

$Palantir (PLTR.US)$ time